Y Jing1, X Yue, S Yang, S Li. 1. Xincan Yue, No. 26 Renmin Road East, Zhoukou, 466000, Henan Province, P. R. China, E-mail: 365201720@qq.com; Tel: +86-0394-8269178; Fax: 86-0394-8269178.
Abstract
OBJECTIVE: To investigate the association of aspirin resistance (AR) with mortality in a cohort of Chinese patients with acute ischemic stroke (AIS). METHODS: One hundred and ninety-six ischemic stroke patients who received at least 7 days of aspirin therapy prior to stroke onset were enrolled. The outcome measure was all-cause and cardiovascular disease (CVD) mortality at 1-year follow-up. The relation of AR with the two end points was investigated with the use of logistic regression models. RESULTS: The median age of included patients was 65(IQR, 56-76) years and 82(41.8%) were female. Thirty-five patients were defined as AR; thus, the rate was 17.9% (95%CI, 12.5% to 23.2%). The median NIHSS score was significantly higher in patients with AR than those with AS [12 (IQR, 10-17) vs. 7 (IQR, 4-10); Z=5.188; P<0.001]. Similarly, the median infarct volume was also significantly higher in AR than in AS [18.8 (IQR, 4.3-25.2) ml vs. 13.2 (IQR, 3.3-18.7) ml; Z=3.322; P=0.008]. During follow-up there were 43 patients (21.9%) died, including 24 CVD mortality (12.2%). In univariate logistic regression analysis, we found that the rate of all-cause mortality and CVD mortality increased by 390% (OR=4.90; 95%CI:2.24-10.75) and 422% (OR=5.22; 95%CI, 2.10-12.98) in AR group. After adjusting for all other significant predictors, AR still associated with high mortality and the rate of all-cause mortality and CVD mortality increased by 215% (OR=3.15; 95%CI:1.88-4.93) and 231% (OR=3.31; 95%CI, 1.96-522), respectively. CONCLUSIONS: The present study shows that AR was a useful prognostic marker of all-cause or CVD mortality in Chinese patients with AIS.
OBJECTIVE: To investigate the association of aspirin resistance (AR) with mortality in a cohort of Chinese patients with acute ischemic stroke (AIS). METHODS: One hundred and ninety-six ischemic strokepatients who received at least 7 days of aspirin therapy prior to stroke onset were enrolled. The outcome measure was all-cause and cardiovascular disease (CVD) mortality at 1-year follow-up. The relation of AR with the two end points was investigated with the use of logistic regression models. RESULTS: The median age of included patients was 65(IQR, 56-76) years and 82(41.8%) were female. Thirty-five patients were defined as AR; thus, the rate was 17.9% (95%CI, 12.5% to 23.2%). The median NIHSS score was significantly higher in patients with AR than those with AS [12 (IQR, 10-17) vs. 7 (IQR, 4-10); Z=5.188; P<0.001]. Similarly, the median infarct volume was also significantly higher in AR than in AS [18.8 (IQR, 4.3-25.2) ml vs. 13.2 (IQR, 3.3-18.7) ml; Z=3.322; P=0.008]. During follow-up there were 43 patients (21.9%) died, including 24 CVDmortality (12.2%). In univariate logistic regression analysis, we found that the rate of all-cause mortality and CVDmortality increased by 390% (OR=4.90; 95%CI:2.24-10.75) and 422% (OR=5.22; 95%CI, 2.10-12.98) in AR group. After adjusting for all other significant predictors, AR still associated with high mortality and the rate of all-cause mortality and CVDmortality increased by 215% (OR=3.15; 95%CI:1.88-4.93) and 231% (OR=3.31; 95%CI, 1.96-522), respectively. CONCLUSIONS: The present study shows that AR was a useful prognostic marker of all-cause or CVDmortality in Chinese patients with AIS.
Authors: A D Michelson; M Cattaneo; J W Eikelboom; P Gurbel; K Kottke-Marchant; T J Kunicki; F M Pulcinelli; C Cerletti; A K Rao Journal: J Thromb Haemost Date: 2005-05-09 Impact factor: 5.824
Authors: Amy S Y Zheng; Leonid Churilov; Ruth E Colley; Christine Goh; Stephen M Davis; Bernard Yan Journal: JAMA Neurol Date: 2013-02 Impact factor: 18.302
Authors: John W Eikelboom; Jack Hirsh; Jeffrey I Weitz; Marilyn Johnston; Qilong Yi; Salim Yusuf Journal: Circulation Date: 2002-04-09 Impact factor: 29.690
Authors: Jaapjan D Snoep; Marcel M C Hovens; Jeroen C J Eikenboom; Johanna G van der Bom; Menno V Huisman Journal: Arch Intern Med Date: 2007 Aug 13-27
Authors: Wai-Hong Chen; Xi Cheng; Pui-Yin Lee; William Ng; Jeanette Yat-Yin Kwok; Hung-Fat Tse; Chu-Pak Lau Journal: Am J Med Date: 2007-07 Impact factor: 4.965
Authors: J R Sims; L Rezai Gharai; P W Schaefer; M Vangel; E S Rosenthal; M H Lev; L H Schwamm Journal: Neurology Date: 2009-06-16 Impact factor: 9.910
Authors: Narayanaswamy Venketasubramanian; Sherwin Joy Agustin; Jorge L Padilla; Maricar P Yumul; Christina Sum; Sze Haur Lee; Kuperan Ponnudurai; Robert N Gan Journal: J Cardiovasc Dev Dis Date: 2022-05-12